BCL9

gene product
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
156 antibodies from 22 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
Invitrogen Antibodies
7 antibodies
antibodies-online
36 antibodies
Novus Biologicals
5 antibodies
NovoPro Bioscience Inc.
3 antibodies
Atlas Antibodies
1 antibody
GeneTex
1 antibody
Biorbyt
10 antibodies
Abgent
1 antibody
LifeSpan BioSciences, Inc.
29 antibodies
Abnova Corporation
3 antibodies
R&D Systems
2 antibodies
Creative Biolabs
5 antibodies
Creative Diagnostics
2 antibodies
Cell Signaling Technology, Inc
1 antibody
RayBiotech, Inc.
1 antibody
United States Biological
27 antibodies
Leading Biology
2 antibodies
MyBioSource
2 antibodies
Sigma-Aldrich
1 antibody
GenWay
1 antibody